Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Comments ·0 Shares ·135 Views ·0 Reviews
Please log in to like, share and comment!